How Is the Patient with AF Treated?
AF patient care pathway management includes rhythm control therapy to restore sinus rhythm during an episode of AF and rate and rhythm control therapies in over the long-term.
Current treatment options available for managing AF include:
Rate Control Therapies
Beta blockers or non-dihydropyridine calcium channel antagonists, digitalis glycosides, or amiodaron
AV node ablation with pacemaker implantation
Rhythm Control Therapies
RHYTHM CONTROL THERAPIES FOR AN EPISODE OF AF
Electrical and pharmacological cardioversion
LONG-TERM RHYTHM CONTROL THERAPIES
Electrical and pharmacological cardioversion is recommended in patients experiencing an episode of AF, and the type of cardioversion chosen is dependent on haemodynamic stability, presence and type of structural heart disease, and patient choice.2
The choice of an alternative rhythm control therapy requires patient involvement, consideration of patient preferences, and informed decision-making with a multidisciplinary team of healthcare professionals, should the first rhythm control strategy fail.2
Patients who experience recurrence of symptomatic AF while on AADs or after catheter ablation may choose to: 2
Treatment with a different AAD
(i.e. combining AADs with ablation)
Rate control therapies to control AF
Treatment options for AF management
The initial management strategy for patients with AF includes detection and management of key complications and cardiovascular risk factors, including stroke and heart failure. Early treatment is important as it may improve patient life expectancy and quality of life.1,2 Treatment options for controlling AF long-term include stroke aversion therapy, rate control therapy and rhythm control strategies. Should you wish to read more on the Treatment options of Atrial Fibrillation, download the full report, the executive summary and the infographic on Atrial Fibrillation Management that have been published by Biosense Webster.
1. Iaizzo PA (2015). Handbook of Cardiac Anatomy, Physiology and Devices. Springer Science and Business Media, LLC: Switzerland.
2. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D et al. (2016) 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37 (38): 2893-2962.
126680-191029 EMEA; 123104-200130 EMEA; 125888-191019 EMEA